Biotech Clubhouse

This Biotech Clubhouse Session will cover insights into best practices for providing access to medicines in the developing from industry experts exploring learnings from Gilead Science’s HIV and Hepatitis C Access to Medicines Program. We take lessons from past efforts, look at the current COVID response, and discuss a path forward for low and middle-income countries’ access to COVID vaccines, as well as future life-saving medicines. Guests: Clifford Samuel, Claudio Lilienfeld, Kash Rangan. Host: Chris Garabedian. Full auto-generated transcript: click here [https://drive.google.com/file/d/1HM-tS2xbZ3gQOtOm33LXaTZs1eaVrIuE/view?usp=sharing] Originally aired on June 7th, 2021 on Biotech Clubhouse. Shared with permission

Companies can change the world for the better while advancing their own business goals by supporting community-building activities. Featuring Life Science Cares (LSC) Impact Breakfast Keynote Speaker, Afdhel Aziz, and hosted by LSC founder, Rob Perez. Originally aired May 27th on Biotech Clubhouse. Click here for transcript [https://drive.google.com/file/d/1U-pkpnEsYhu9yziFiWtDeHDFh50jF7v6/view?usp=sharing] (autogenerated)

A cross-disciplinary group of oncology experts and a top wall street biotech analyst discuss the most promising new therapies presenting data at ASCO. Featuring Sally Church, James Gulley, Aleksandra Filipovic, and Umer Raffat. Moderated by Daphne Zohar. Originally aired May 21st on Biotech Clubhouse. Click for transcript [https://otter.ai/u/-nqbKFxKLeZacMkhvMfoK4GFJvo]